Literature DB >> 3135718

Transvenous embolization of direct carotid cavernous fistulas.

V V Halbach1, R T Higashida, G B Hieshima, C W Hardin, P J Yang.   

Abstract

Of 165 cases of direct carotid cavernous fistula, 14 (8.5%) were treated from a transvenous approach. Twelve of these were treated through the inferior petrosal sinus and one through the superior ophthalmic vein. In one patient, both approaches were used. The embolic agents were as follows: five patients had balloons only, four patients had minicoils alone, three patients had coils and liquid adhesives, one had balloons and coils, and one had balloons and liquid adhesives. Among the patients who were treated from a transvenous approach, three had an occluded carotid artery caused by trauma, nine failed transarterial balloon attempts, and one had a prior trapping procedure. In the remaining patient, who had Ehlers-Danlos syndrome, a transarterial approach was judged to be too dangerous. This patient suffered a fatal pontine hemorrhage after subtotal transvenous occlusion of the carotid cavernous fistula with diversion of flow into cortical veins. Another complication occurred when the inferior petrosal sinus was perforated during catheterization, causing a small subarachnoid hemorrhage. The tear was immediately closed with minicoils, and surgical exposure and embolization resulted in complete cure. Of the remaining 12 patients treated, 11 were completely cured and one showed angiographic and clinical improvement. Transarterial balloon embolization remains the procedure of choice in the treatment of symptomatic carotid cavernous fistulas; however, transvenous embolization is an alternative when the arterial route fails.

Entities:  

Mesh:

Year:  1988        PMID: 3135718      PMCID: PMC8332015     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  53 in total

1.  Double-balloon technique for embolization of carotid cavernous fistulas.

Authors:  M M Teng; C Y Chang; J H Chiang; J F Lirng; C B Luo; S S Chen; F C Chang; W Y Guo
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

2.  Arteriovenous fistulae of the CNS.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

Review 3.  Cavernous sinus fistulas: carotid cavernous fistulas and dural arteriovenous malformations.

Authors:  Leonard Feiner; Jeffrey Bennett; Nicholas J Volpe
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

4.  Double traumatic caroticocavernous fistula and its treatment by detachable balloons.

Authors:  S Kumar; R V Phadke; B Mazumdar; S Roy; R B Gujral
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

5.  Treatment of carotid cavernous fistulas.

Authors:  Joseph J Gemmete; Neeraj Chaudhary; Aditya Pandey; Sameer Ansari
Journal:  Curr Treat Options Neurol       Date:  2010-01       Impact factor: 3.598

6.  Support balloon as assistance for detachable balloon technique in carotid cavernous fistula.

Authors:  A Casasco; N Sourour; E Vivas; A Biondi; C Marsault
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

7.  Treatment of traumatic carotid-cavernous fistula.

Authors:  Z Wu; Y Zhang; C Wang; X Yang; Y Li
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

8.  A case of aberrant abducens nerve in a cadaver and review of its clinical significance.

Authors:  Chan-Young Choi; Seong-Rok Han; Gi-Taek Yee; Chae-Heuck Lee
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

9.  Transarterial Embolization of Direct Carotid Cavernous Fistulas with the Double-balloon Technique.

Authors:  Yuan Hsiung Tsai; Ho Fai Wong; Yao Liang Chen; Hsu Huei Weng
Journal:  Interv Neuroradiol       Date:  2009-01-02       Impact factor: 1.610

10.  Treatment of Trapped CCF by Direct Puncture of the Cavernous Sinus by Infraocular Trans-SOF Approach. Case Report and Anatomical Basis.

Authors:  M J Workman; J E Dion; F C Tong; H J Cloft
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.